Liabilities and Equity of Liminatus Pharma, Inc. from 31 Dec 2024 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Liminatus Pharma, Inc. quarterly Liabilities and Equity in USD history and change rate from 31 Dec 2024 to 30 Sep 2025.
  • Liminatus Pharma, Inc. Liabilities and Equity for the quarter ending 30 Sep 2025 was $1,342,409.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)

Liminatus Pharma, Inc. Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,342,409 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $1,908,781 30 Jun 2025 10-Q 06 Oct 2025 2025 Q2
Q4 2024 $5,408,859 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.